Product news

Share this article:

Mylan Pharmaceuticals received final approval from the FDA for its Abbreviated New Drug Application for Doxycycline Tablets, 150 mg. Doxycycline Tablets are the generic version of Par Pharmaceutical's Doxycycline Tablets, 150 mg, marketed as Adoxa  Tablets by Doak Dermatologics. Doxycycline Tablets had US sales of approximately $34 million for the 12 months ending March 31, 2007 for the 150 mg. strength. In addition to this new product strength, Mylan previously received approval and is marketing the 50 mg, 75 mg and 100 mg strengths of Doxycycline Tablets.


 

King Pharmaceuticals announced plans to discontinue Florinef (fludrocortisone acetate tablets, USP), a drug used as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease for the treatment of salt losing adrenogenital syndrome.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.